Fezolinetant Shows Potential as Treatment for Vasomotor Symptoms in Postmenopausal Women, but Safety Profile Needs Further Research

https://pubmed.ncbi.nlm.nih.gov/38115258

Fezolinetant, a neurokinin-3 antagonist, shows potential as a treatment for vasomotor symptoms in postmenopausal women, although further research is needed to fully assess its safety profile, particularly the risk of endometrial hyperplasia or tumors.